These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 12926186)

  • 1. Immunotherapy with an extract of Olea europaea quantified in mass units. Evaluation of the safety and efficacy after one year of treatment.
    González P; Florido F; Sáenz de San Pedro B; de la Torre F; Rico P; Martín S
    J Investig Allergol Clin Immunol; 2002; 12(4):263-71. PubMed ID: 12926186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy with a depigmented, polymerized vaccine of Olea europaea pollen allergens. Significantly reduces specific bronchial and skin test reactivity in sensitized patients after one year of treatment.
    Guerra F; Daza JC; Almeda E
    J Investig Allergol Clin Immunol; 2003; 13(2):108-17. PubMed ID: 12968395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy.
    Czarnecka-Operacz M; Jenerowicz D; Silny W
    Acta Dermatovenerol Croat; 2008; 16(1):19-24. PubMed ID: 18358104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phoenix sylvestris Roxb pollen allergy: a 2-year randomized controlled trial and follow-up study of immunotherapy in patients with seasonal allergy in an agricultural area of West Bengal, India.
    Chakraborty P; Roy I; Chatterjee S; Chanda S; Gupta-Bharracharya S
    J Investig Allergol Clin Immunol; 2006; 16(6):377-84. PubMed ID: 17153886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG4 levels in relation to Olea europaea immunotherapy.
    Guerra F; Moreno C; Daza JC; García M; Arenas A; Miguel R; Sánchez Guijo P
    J Investig Allergol Clin Immunol; 1992; 2(6):307-12. PubMed ID: 1342914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen.
    Wüthrich B; Bucher Ch; Jörg W; Bircher A; Eng P; Schneider Y; Schnyder F; Eigenmann P; Senti G
    J Investig Allergol Clin Immunol; 2003; 13(3):145-8. PubMed ID: 14635462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
    García Villalmanzo I; Hernández MD; Campos A; Giner AM; Polo F; Cortés C; Basomba A
    J Investig Allergol Clin Immunol; 1999; 9(5):321-9. PubMed ID: 10582201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study.
    Mirone C; Albert F; Tosi A; Mocchetti F; Mosca S; Giorgino M; Pecora S; Parmiani S; Ortolani C
    Clin Exp Allergy; 2004 Sep; 34(9):1408-14. PubMed ID: 15347374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen.
    Patel P; Holdich T; Fischer von Weikersthal-Drachenberg KJ; Huber B
    J Allergy Clin Immunol; 2014 Jan; 133(1):121-9.e1-2. PubMed ID: 23870670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization.
    Vourdas D; Syrigou E; Potamianou P; Carat F; Batard T; André C; Papageorgiou PS
    Allergy; 1998 Jul; 53(7):662-72. PubMed ID: 9700035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of specific immunotherapy with standardized allergenic extracts adsorbed on aluminium hydroxide.
    Wüthrich B; Gumowski PL; Fäh J; Hürlimann A; Deluze C; André C; Fadel R; Carat F
    J Investig Allergol Clin Immunol; 2001; 11(3):149-56. PubMed ID: 11831445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with a Phleum pratense allergen extract induces an immune response to a grass-mix allergen extract.
    Martínez-Cócera C; Sastre J; Cimarra M; Quirce S; Fernández-Rivas M; Enríquez-Matas A; Rodríguez-Alvarez M; Martín S
    J Investig Allergol Clin Immunol; 2010; 20(1):13-9. PubMed ID: 20232769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olive, grass or both? Molecular diagnosis for the allergen immunotherapy selection in polysensitized pollinic patients.
    Moreno C; Justicia JL; Quiralte J; Moreno-Ancillo A; Iglesias-Cadarso A; Torrecillas M; Labarta N; García MA; Dávila I
    Allergy; 2014 Oct; 69(10):1357-63. PubMed ID: 24988991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
    Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.